ah 13205 has been researched along with ah 23848 in 2 studies
| Studies (ah 13205) | Trials (ah 13205) | Recent Studies (post-2010) (ah 13205) | Studies (ah 23848) | Trials (ah 23848) | Recent Studies (post-2010) (ah 23848) |
|---|---|---|---|---|---|
| 16 | 0 | 1 | 89 | 3 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, RA; Milne, SA; Woodward, DF | 1 |
| Barnes, PJ; Giembycz, MA; Meja, KK | 1 |
2 other study(ies) available for ah 13205 and ah 23848
| Article | Year |
|---|---|
Comparison of the EP receptor subtypes mediating relaxation of the rabbit jugular and pig saphenous veins.
Topics: 16,16-Dimethylprostaglandin E2; Alprostadil; Animals; Biphenyl Compounds; Endothelium, Vascular; Jugular Veins; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Prostaglandins F, Synthetic; Prostanoic Acids; Rabbits; Receptors, Prostaglandin E; Saphenous Vein; Swine | 1995 |
Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Biphenyl Compounds; Dinoprostone; Drug Interactions; Epoprostenol; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Prostaglandin Antagonists; Prostaglandin Endoperoxides, Synthetic; Prostanoic Acids; Receptors, Prostaglandin; Thromboxane A2; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 1997 |